FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076649973> ?p ?o ?g. }

• W2076649973 endingPage "120" @default.
• W2076649973 startingPage "108" @default.
• W2076649973 abstract "A working group convened at the 2009 5th IWGT to discuss possibilities for improving in vivo genotoxicity assessment by investigating possible links to standard toxicity testing. The working group considered: (1) combination of acute micronucleus (MN) and Comet assays into a single study, (2) integration of MN assays into repeated-dose toxicity (RDT) studies, (3) integration of Comet assays into RDT studies, and (4) requirements for the top dose when integrating genotoxicity measurements into RDT studies. The working group reviewed current requirements for in vivo genotoxicity testing of different chemical product classes and identified opportunities for combination and integration of genotoxicity endpoints for each class. The combination of the acute in vivo MN and Comet assays was considered by the working group to represent a technically feasible and scientifically acceptable alternative to conducting independent assays. Two combination protocols, consisting of either a 3- or a 4-treament protocol, were considered equally acceptable. As the integration of MN assays into RDT studies had already been discussed in detail in previous IWGT meetings, the working group focussed on factors that could affect the results of the integrated MN assay, such as the possible effects of repeated bleeding and the need for early harvests. The working group reached the consensus that repeated bleeding at reasonable volumes is not a critical confounding factor for the MN assay in rats older than 9 weeks of age and that rats bled for toxicokinetic investigations or for other routine toxicological purposes can be used for MN analysis. The working group considered the available data as insufficient to conclude that there is a need for an early sampling point for MN analysis in RDT studies, in addition to the routine determination at terminal sacrifice. Specific scenarios were identified where an additional early sampling can have advantages, e.g., for compounds that exert toxic effects on hematopoiesis, including some aneugens. For the integration of Comet assays into RDT studies, the working group reached the consensus that, based upon the limited amount of data available, integration is scientifically acceptable and that the liver Comet assay can complement the MN assay in blood or bone marrow in detecting in vivo genotoxins. Practical issues need to be considered when conducting an integrated Comet assay study. Freezing of tissue samples for later Comet assay analysis could alleviate logistical problems. However, the working group concluded that freezing of tissue samples can presently not be recommended for routine use, although it was noted that results from some laboratories look promising. Another discussion topic centred around the question as to whether tissue toxicity, which is more likely observed in RDT than in acute toxicity studies, would affect the results of the Comet assay. Based on the available data from in vivo studies, the working group concluded that there are no clear examples where cytotoxicity, by itself, generates increases or decreases in DNA migration. The working group identified the need for a refined guidance on the use and interpretation of cytotoxicity methods used in the Comet assay, as the different methods used generally lead to inconsistent conclusions. Since top doses in RDT studies often are limited by toxicity that occurs only after several doses, the working group discussed whether the sensitivity of integrated genotoxicity studies is reduced under these circumstances. For compounds for which in vitro genotoxicity studies yielded negative results, the working group reached the consensus that integration of in vivo genotoxicity endpoints (typically the MN assay) into RDT studies is generally acceptable. If in vitro genotoxicity results are unavailable or positive, consensus was reached that the maximum tolerated dose (MTD) is acceptable as the top dose in RDT studies in many cases, such as when the RDT study MTD or exposure is close (50% or greater) to an acute study MTD or exposure. Finally, the group agreed that exceptions to this general rule might be acceptable, for example when human exposure is lower than the preclinical exposure by a large margin." @default.
• W2076649973 created "2016-06-24" @default.
• W2076649973 creator A5009869895 @default.
• W2076649973 creator A5011500193 @default.
• W2076649973 creator A5017541332 @default.
• W2076649973 creator A5018384211 @default.
• W2076649973 creator A5035119519 @default.
• W2076649973 creator A5037354929 @default.
• W2076649973 creator A5038573409 @default.
• W2076649973 creator A5040191987 @default.
• W2076649973 creator A5041820221 @default.
• W2076649973 creator A5056141783 @default.
• W2076649973 creator A5067929281 @default.
• W2076649973 creator A5068085304 @default.
• W2076649973 creator A5069354935 @default.
• W2076649973 creator A5070432758 @default.
• W2076649973 creator A5071939226 @default.
• W2076649973 creator A5074425018 @default.
• W2076649973 creator A5085597309 @default.
• W2076649973 creator A5055247601 @default.
• W2076649973 date "2011-08-01" @default.
• W2076649973 modified "2023-10-18" @default.
• W2076649973 title "Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing" @default.
• W2076649973 cites W153016016 @default.
• W2076649973 cites W1977342842 @default.
• W2076649973 cites W1977402553 @default.
• W2076649973 cites W1984358216 @default.
• W2076649973 cites W1986792490 @default.
• W2076649973 cites W1988252528 @default.
• W2076649973 cites W1992170343 @default.
• W2076649973 cites W1999859052 @default.
• W2076649973 cites W2004070825 @default.
• W2076649973 cites W2010689901 @default.
• W2076649973 cites W2013934383 @default.
• W2076649973 cites W2016292944 @default.
• W2076649973 cites W2018116549 @default.
• W2076649973 cites W2022967579 @default.
• W2076649973 cites W2024691286 @default.
• W2076649973 cites W2026724232 @default.
• W2076649973 cites W2034840789 @default.
• W2076649973 cites W2039698989 @default.
• W2076649973 cites W2040927738 @default.
• W2076649973 cites W2046908575 @default.
• W2076649973 cites W2048438253 @default.
• W2076649973 cites W2052086476 @default.
• W2076649973 cites W2053493344 @default.
• W2076649973 cites W2060361758 @default.
• W2076649973 cites W2063590763 @default.
• W2076649973 cites W2064389706 @default.
• W2076649973 cites W2068949125 @default.
• W2076649973 cites W2074317481 @default.
• W2076649973 cites W2078875440 @default.
• W2076649973 cites W2079141357 @default.
• W2076649973 cites W2090344394 @default.
• W2076649973 cites W2095934923 @default.
• W2076649973 cites W2105099536 @default.
• W2076649973 cites W2115006670 @default.
• W2076649973 cites W2119346782 @default.
• W2076649973 cites W2119673466 @default.
• W2076649973 cites W2121443549 @default.
• W2076649973 cites W2126902508 @default.
• W2076649973 cites W2130515759 @default.
• W2076649973 cites W2134332528 @default.
• W2076649973 cites W2138985153 @default.
• W2076649973 cites W2143367473 @default.
• W2076649973 cites W2146021438 @default.
• W2076649973 cites W2152009515 @default.
• W2076649973 cites W2161309067 @default.
• W2076649973 cites W2161971257 @default.
• W2076649973 cites W2163699185 @default.
• W2076649973 cites W2165793882 @default.
• W2076649973 cites W2170445850 @default.
• W2076649973 cites W2171360288 @default.
• W2076649973 cites W4248276732 @default.
• W2076649973 cites W4250387519 @default.
• W2076649973 cites W90094331 @default.
• W2076649973 doi "https://doi.org/10.1016/j.mrgentox.2010.12.005" @default.
• W2076649973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21182982" @default.
• W2076649973 hasPublicationYear "2011" @default.
• W2076649973 type Work @default.
• W2076649973 sameAs 2076649973 @default.
• W2076649973 citedByCount "85" @default.
• W2076649973 countsByYear W20766499732012 @default.
• W2076649973 countsByYear W20766499732013 @default.
• W2076649973 countsByYear W20766499732014 @default.
• W2076649973 countsByYear W20766499732015 @default.
• W2076649973 countsByYear W20766499732016 @default.
• W2076649973 countsByYear W20766499732017 @default.
• W2076649973 countsByYear W20766499732018 @default.
• W2076649973 countsByYear W20766499732019 @default.
• W2076649973 countsByYear W20766499732020 @default.
• W2076649973 countsByYear W20766499732021 @default.
• W2076649973 countsByYear W20766499732022 @default.
• W2076649973 countsByYear W20766499732023 @default.
• W2076649973 crossrefType "journal-article" @default.
• W2076649973 hasAuthorship W2076649973A5009869895 @default.
• W2076649973 hasAuthorship W2076649973A5011500193 @default.
• W2076649973 hasAuthorship W2076649973A5017541332 @default.

• next